GILEAD SCIENCES, INC. (GILD) FY2026 Q1 Balance Sheet

Balance Sheet

As of 2026-03-31

Swipe to see the full flow
GILEAD SCIENCES, INC. (GILD) FY2026 Q1 Balance SheetBalance sheet as of 2026-03-31. The chart shows assets, liabilities and equity at that date.Current liabilities$9.48 BLiabilities(calculated)$32.85 BCurrent assets$18.64 BAssets$56.28 BNon-current liabilities$23.37 BNon-current assets$37.64 BEquity$23.43 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSCash and cash equivalentsAccounts receivable, netPrepaid and other current assetsInventoriesShort-term marketable debt securitiesIntangible assets, netGoodwillProperty, plant and equipment, netOther long-term assetsDeferred tax assetsLong-term marketable debt securitiesAccrued rebatesOther current liabilitiesCurrent portion of long-term debt, netAccounts payableLong-term debt, netOther long-term liabilitiesLong-term income taxes payableDeferred tax liabilitiesRetained earningsAdditional paid-in capitalAccumulated other comprehensive incomeCommon stock, par value $0.001 per share; 5,600 shares authorized; 1,242 and 1,241 shares issued and outstanding, respectivelyNoncontrolling interestCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilities (calculated)EquityAccrued rebatesAccrued rebates$4.12 BCurrent liabilitiesCurrent liabilities$9.48 BOther current liabilitiesOther current liabilities$3.40 BLiabilities (calculated)Liabilities(calculated)$32.85 BCash and cash equivalentsCash and cash equivalents$7.63 BCurrent portion of long-term debt, netCurrent portion of long-term debt, net$1.31 BCurrent assetsCurrent assets$18.64 BAccounts receivable, netAccounts receivable, net$4.74 BAccounts payableAccounts payable$645.00 MPrepaid and other current assetsPrepaid and other current assets$4.34 BAssetsAssets$56.28 BNon-current liabilitiesNon-current liabilities$23.37 BInventoriesInventories$1.91 BLong-term debt, netLong-term debt, net$20.86 BShort-term marketable debt securitiesShort-term marketable debt securities$15.00 MOther long-term liabilitiesOther long-term liabilities$1.20 BNon-current assetsNon-current assets$37.64 BIntangible assets, netIntangible assets, net$16.38 BLong-term income taxes payableLong-term income taxes payable$918.00 MDeferred tax liabilitiesDeferred tax liabilities$392.00 MGoodwillGoodwill$8.31 BEquityEquity$23.43 BProperty, plant and equipment, netProperty, plant and equipment, net$5.64 BRetained earningsRetained earnings$14.13 BOther long-term assetsOther long-term assets$4.55 BAdditional paid-in capitalAdditional paid-in capital$9.31 BDeferred tax assetsDeferred tax assets$1.77 BAccumulated other comprehensive incomeAccumulated other comprehensive income$78.00 MLong-term marketable debt securitiesLong-term marketable debt securities$983.00 MCommon stock, par value $0.001 per share; 5,600 shares authorized; 1,242 and 1,241 shares issued and outstanding, respectivelyCommon stock$1.00 MNoncontrolling interestNoncontrolling interest−$84.00 M
Chart details

GILEAD SCIENCES, INC. (GILD) FY2026 Q1 Balance Sheet

Balance sheet as of 2026-03-31. The chart shows assets, liabilities and equity at that date.

Assets
56,278,000,000 US dollars
Current assets
18,641,000,000 US dollars
Non-current assets
37,637,000,000 US dollars
Liabilities (calculated)
32,847,000,000 US dollars
Current liabilities
9,476,000,000 US dollars
Non-current liabilities
23,371,000,000 US dollars
Equity
23,431,000,000 US dollars
Noncontrolling interest
negative 84,000,000 US dollars. Included in consolidated equity; this amount is not added again.
Cash and cash equivalents
7,628,000,000 US dollars
Accounts receivable, net
4,741,000,000 US dollars
Prepaid and other current assets
4,342,000,000 US dollars
Inventories
1,914,000,000 US dollars
Short-term marketable debt securities
15,000,000 US dollars
Intangible assets, net
16,382,000,000 US dollars
Goodwill
8,314,000,000 US dollars
Property, plant and equipment, net
5,638,000,000 US dollars
Other long-term assets
4,554,000,000 US dollars
Deferred tax assets
1,767,000,000 US dollars
Long-term marketable debt securities
983,000,000 US dollars
Accrued rebates
4,118,000,000 US dollars
Other current liabilities
3,399,000,000 US dollars
Current portion of long-term debt, net
1,313,000,000 US dollars
Accounts payable
645,000,000 US dollars
Long-term debt, net
20,861,000,000 US dollars
Other long-term liabilities
1,200,000,000 US dollars
Long-term income taxes payable
918,000,000 US dollars
Deferred tax liabilities
392,000,000 US dollars
Retained earnings
14,131,000,000 US dollars
Additional paid-in capital
9,305,000,000 US dollars
Accumulated other comprehensive income
78,000,000 US dollars
Common stock, par value $0.001 per share; 5,600 shares authorized; 1,242 and 1,241 shares issued and outstanding, respectively
1,000,000 US dollars
Preferred stock, par value $0.001 per share; 5 shares authorized; none outstanding
0 US dollars
Noncontrolling interest
negative 84,000,000 US dollars

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
  • The filed current assets lines add up to $18,640.00 M and the current assets total is $18,641.00 M; the $1.00 M difference is within the rounding of the filed amounts.
  • The filed non-current assets lines add up to $37,638.00 M and the non-current assets total is $37,637.00 M; the $1.00 M difference is within the rounding of the filed amounts.
  • The filed current liabilities lines add up to $9,475.00 M and the current liabilities total is $9,476.00 M; the $1.00 M difference is within the rounding of the filed amounts.
GILEAD SCIENCES, INC. (GILD) FY2026 Q1 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!